Erk5 and its potential applications in cancer treatment
2024-06-14
(Press-News.org)
“Elucidating the function of Erk5 in cancer [...] will contribute to a better understanding of cancer pathogenesis and the development of novel therapeutic strategies.”
BUFFALO, NY- June 14, 2024 – A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Role of Erk5 expressed in bone marrow mesenchymal stem cells on bone homeostasis and its potential applications in cancer treatment.”
In their new editorial, researchers Tetsuhiro Horie and Eiichi Hinoi from Kanazawa Medical University, Gifu Pharmaceutical University, and Gifu University discuss Extracellular signal-regulated kinase 5 (Erk5). Erk5 belongs to the mitogen-activated protein kinase (MAPK) family and is specifically phosphorylated and subsequently activated by MAPK/Erk5 kinase 5 (Mek5) [1]. Compared to classical MAPKs Erk1/2, Erk5 is unique in that it has distinctive structures on its C-terminus with two proline-rich domains and a nuclear localization signal domain, which regulate autophosphorylation and transcription.
“Erk5 signaling is activated by hypoxia, oxidative stress, cytokines and growth factors, and is involved in angiogenesis, neurogenesis and energy metabolism, as well as tumor growth and metastasis [2, 3].”
Bone homeostasis is maintained by the coordinated activities of osteoclasts (bone-resorbing cells) and osteoblasts (bone-forming cells) derived from hematopoietic stem cells (HSCs) and bone marrow mesenchymal stem cells (BM-MSCs), respectively. Bone diseases such as osteoporosis and osteopetrosis are caused by an imbalance between bone resorption and formation due to aging, menopause, genetic mutations, etc. Previously, using paired-related homeobox 1 (Prx1)-Cre; Erk5fl/fl mice (MSC-specific Erk5 knockout mice), the researchers showed that Erk5 activates Smad-specific E3 ubiquitin protein ligase 2 (Smurf2) by directly phosphorylating Thr249 (Smurf2T249) and regulates skeletal development during embryogenesis by inducing the degradation of Smad1 protein, but the function of Erk5 in BM-MSCs in adulthood was not clear [4].
“Therefore, we generated and analyzed conditional Erk5 knockout mice (LepR-Cre; Erk5fl/fl mice) using leptin receptor (LepR)-Cre, which targets adult BM-MSCs [5, 6].”
Continue reading: DOI: https://doi.org/10.18632/oncoscience.601
Correspondence to: Eiichi Hinoi
Email: hinoi-e@gifu-pu.ac.jp
Keywords: bone marrow mesenchymal stem cell, extracellular signal-regulated kinase 5, Smad-specific E3 ubiquitin protein ligase 2, cancer, stem cell niche
About Oncoscience:
About Oncoscience:
Oncoscience is a peer-reviewed, open-access, traditional journal covering the rapidly growing field of cancer research, especially emergent topics not currently covered by other journals. This journal has a special mission: Freeing oncology from publication cost. It is free for the readers and the authors.
Oncoscience is indexed and archived by PubMed, PubMed Central, Scopus, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).
To learn more about Oncoscience, visit Oncoscience.us and connect with us on social media:
X, formerly Twitter
Instagram
Facebook
YouTube
LinkedIn
For media inquiries, please contact media@impactjournals.com.
Oncoscience Journal Office
6666 East Quaker Str., Suite 1D
Orchard Park, NY 14127
Phone: 1-800-922-0957, option 4
###
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2024-06-14
(MEMPHIS, Tenn. – June 14, 2024) Scientists at St. Jude Children’s Research Hospital today announced a way to improve molecular scale distance measurements using single-molecule fluorescence resonance energy transfer (smFRET). smFRET quantifies the excitation and emission properties of chemicals called fluorophores.
When an excited electron in the fluorophore relaxes, it emits light after a delay, causing the molecule to glow (fluoresce). However, fluorophores don’t always fluoresce after excitation. Instead, through quantum mechanical ...
2024-06-14
SAN ANTONIO, June 14, 2024 – The University of Texas Health Science Center at San Antonio School of Dentistry is preparing to launch its Center for Regenerative Sciences, a new research initiative that aims to position the university at the forefront of regenerative dentistry and medicine.
“The center will provide new avenues for interdisciplinary collaborations to accelerate the translation of preclinical discoveries into therapeutic benefit for patients suffering from dental, oral and craniofacial diseases,” said Yong-Hee Chun, DDS, PhD, MS, associate professor of ...
2024-06-14
In a major breakthrough for lithium recovery technologies, researchers from the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of the Chinese Academy of Sciences, together with collaborators, have developed a crystalline carbon nitride membrane that could transform the lithium extraction industry.
The innovative design, which mimics biological ion channels, shows remarkable efficiency and durability in separating lithium ions from magnesium ions in salt-lake brine.
The study, published in Science Advances on June 14, introduces a ...
2024-06-14
KEY TAKEAWAYS
Lung cancer is the most diagnosed cancer and the leading cause of cancer death globally, representing an urgent need for new and improved treatment options.
Researchers from Brigham and Women’s Hospital developed a new nanomedicine therapy that delivers anticancer drugs to lung cancer cells and enhances the immune system's ability to fight cancer.
The research must undergo rigorous toxicology studies before moving into clinical testing in patients but represents a potential treatment for patients who have failed to respond to traditional immunotherapy.
Researchers at Brigham and ...
2024-06-14
Atlanta, GA – June 14, 2024 – Antibiotics in the uppermost water surface, known as the sea surface microlayer, can significantly affect the number of bacteria present and contribute to the adaptation of marine bacteria against widely used antibiotics. In new research presented at ASM Microbe, scientists directly assessed the potential effects of antibiotics on bacterial diversity in Jade Bay, Southern North Sea, Germany.
The researchers tested the susceptibility and resistance of marine bacteria to ofloxacin, ...
2024-06-14
Atlanta, GA—Sepsis is a life-threatening infection complication and accounts for 1.7 million hospitalizations and 350,000 deaths annually in the U.S. Fast and accurate diagnosis is critical, as mortality risk increases up to 8% every hour without effective treatment. However, the current diagnostic standard is reliant on culture growth, which typically takes 2-3 days. Doctors may choose to administer broad-spectrum antibiotics until more information is available for an accurate diagnosis, but these can have limited efficacy and potential toxicity to the patient.
In a study presented at ASM Microbe, a team from Day Zero Diagnostics unveiled a novel approach to antimicrobial susceptibility ...
2024-06-14
A team of researchers led by Philip Walther at the University of Vienna carried out a pioneering experiment where they measured the effect of the rotation of Earth on quantum entangled photons. The work, just published in Science Advances, represents a significant achievement that pushes the boundaries of rotation sensitivity in entanglement-based sensors, potentially setting the stage for further exploration at the intersection between quantum mechanics and general relativity.
Optical Sagnac interferometers are the most sensitive devices to rotations. They have been pivotal in our understanding of fundamental physics since the early years of the last century, contributing to establish ...
2024-06-14
Atlanta, Ga. – June 14, 2023 – Researchers have demonstrated that a new technology could quickly and accurately diagnose bloodstream infections. The study findings were reported at ASM Microbe, the annual meeting of the American Society for Microbiology.
“There is a need to be able to rapidly and accurately diagnose bacteremia in newborn babies. They are especially susceptible to long-term morbidities and mortality the longer they go without treatment, or even with inaccurate treatment for bloodstream infections or sepsis,” said presenting study author April Aralar, Ph.D., a ...
2024-06-14
Background: We previously demonstrated the successful use of in vivo CRISPR gene editing to delete 4-hydroxyphenylpyruvate dioxygenase (HPD) to rescue mice deficient in fumarylacetoacetate hydrolase (FAH), a disorder known as hereditary tyrosinemia type 1 (HT1). The aim of this study was to develop an ex vivo gene-editing protocol and apply it as a cell therapy for HT1.
Methods: We isolated hepatocytes from wild-type (C57BL/6J) and Fah-/- mice and then used an optimized electroporation protocol to deliver Hpd-targeting CRISPR-Cas9 ribonucleoproteins into hepatocytes. Next, hepatocytes were transiently incubated in ...
2024-06-14
University of Georgia-based startup CyanVac LLC received federal funding to support a comparative Phase 2b clinical trial of CVXGA, the company’s intranasal vaccine candidates designed to protect against COVID-19.
As part of the award from Project NextGen, a federal initiative based in the U.S. Department of Health and Human Services (HHS), CyanVac will sponsor a randomized, double-blind Phase 2b study with 10,000 participants to compare the efficacy and safety of the intranasal vaccine against an FDA-approved mRNA-based COVID-19 vaccine.
The new vaccine is based on a viral delivery platform developed by He containing modified ...
LAST 30 PRESS RELEASES:
[Press-News.org] Erk5 and its potential applications in cancer treatment
